Motivational Interviewing-Cognitive Behavioral Therapy Ketogenic Nutrition Adherence Program for Adherence, Patient

1
Effectiveness
1
Safety
Florida State University, Tallahassee, FL
+3 More
Motivational Interviewing-Cognitive Behavioral Therapy Ketogenic Nutrition Adherence Program - Behavioral
Eligibility
18+
All Sexes
Eligible conditions
Adherence, Patient

Study Summary

MI-CBT Adherence Program for Lifestyle Interventions in Older Adults

See full description

Eligible Conditions

  • Ketosis
  • Cognitive Decline
  • Adherence, Patient
  • Cognitive Dysfunction
  • Mild Cognitive Impairment (MCI)

Treatment Effectiveness

Study Objectives

This trial is evaluating whether Motivational Interviewing-Cognitive Behavioral Therapy Ketogenic Nutrition Adherence Program will improve 3 primary outcomes and 1 secondary outcome in patients with Adherence, Patient. Measurement will happen over the course of 5 weeks.

5 weeks
Ketosis (adherence)
6 weeks
Clinical signal of effect
6-weeks
Acceptability
Retention

Trial Safety

Trial Design

2 Treatment Groups

KN Information-Only Program
MI-CBT KNA Program

This trial requires 40 total participants across 2 different treatment groups

This trial involves 2 different treatments. Motivational Interviewing-Cognitive Behavioral Therapy Ketogenic Nutrition Adherence Program is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

MI-CBT KNA Program
Behavioral
The program is a 6-week group, telehealth intervention for older adults with possible MCI. The intervention uses Motivational interviewing and cognitive behavioral therapy strategies to enhance motivation and help participants overcome personal obstacles to following health-behavior recommendations. Specifically, the program examines the use of a Mediterranean ketogenic type of nutrition to target mild cognitive impairment. The intervention is designed to disseminate practical information to help older adults learn how to incorporate healthy Mediterranean ketogenic nutrition into their lifestyle.
KN Information-Only Program
Other
6-week group, telehealth intervention for older adults. The intervention is designed to disseminate practical information to help older adults learn how to incorporate healthy Mediterranean ketogenic nutrition into their lifestyle.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Motivational Interviewing-Cognitive Behavioral Therapy Ketogenic Nutrition Adherence Program
2019
N/A
~10

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6-weeks
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly 6-weeks for reporting.

Who is running the study

Principal Investigator
J. S.
Prof. Julia Sheffler, Clinical Assistant Professor
Florida State University

Closest Location

Florida State University - Tallahassee, FL

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 6 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
Meets criteria for possible mild cognitive impairment
Telephone MoCA Score of greater than 12
Reports interest in participating in the described nutrition intervention
English speaking
Has internet access with video conferencing capability and access to a computer, iPad, or other tablet.
Aged 60-85 years

Patient Q&A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the signs of cognitive decline?

Add answer

In the last 4 years, there are more individuals diagnosed with dementia than in the past. Cognitive decline leads to impaired long-term memory and attention. This may be a clue indicative of cognitive decline.

Unverified Answer

What is cognitive decline?

Add answer

Cognitive decline, a combination of executive, visual and spatial cognition, is a predictor of future disability in this population of community-living adults, especially in patients with concurrent disease. Results from a recent paper warrant further investigation into the relationship of these deficits to the pathology of Alzheimer's disease.

Unverified Answer

Can cognitive decline be cured?

Add answer

Cognitive decline is a natural part of normal aging, rather than a disease. If diagnosed and treated correctly, people with the syndrome can lead full and active lives, with much of it in the spirit of adventure despite old age. Therefore, the most that can be expected is to be able to mitigate memory loss and slowing. The best evidence for this was that cognitive impairment and declines in abilities after age 40 were associated, not worsened by, a higher risk of mortality. Because the cognitive symptoms were common and more common in older people than in young people, the cognitive effects of cognition can be expected to increase with age in a normal aging population. In the current situation, cognitive decline as a disease state was not supported.

Unverified Answer

What are common treatments for cognitive decline?

Add answer

Cognitive decline is often treated through CBT, counseling, medical therapy, counseling, and education support. There is no cure for dementia, so therapy is often focused on symptom management and is highly dependent on individual cases.

Unverified Answer

How many people get cognitive decline a year in the United States?

Add answer

At least 6 million Americans are predicted to have declines in one or all aspects of global cognition within the next 10 years. Because the strongest predictor of cognitive decline is subjective memory complaints, efforts to preserve and maintain cognitive function in old age should include memory-specific interventions.

Unverified Answer

What causes cognitive decline?

Add answer

In many people with dementia, there is a progressive loss of memory and thought, and these issues are the main concerns of carers. Because these impairments do not develop when cognition is examined in isolation, it is probable that there is a large part of the brain which can maintain cognitive function. Cognitive change tends to coincide with neurological disease of a peripheral aetiology. This is particularly reflected in the cognitive deficits in vascular dementias.

Unverified Answer

What is motivational interviewing-cognitive behavioral therapy ketogenic nutrition adherence program?

Add answer

The motivational interviewing-cognitive behavioral program was well-received by patients and physicians, and it was effective in increasing ketogenic diet adherence. Patients who demonstrated a better sense of meaning of keto had improved ketogenic diet adherence. In a recent study, findings suggest that motivational interviewing-cognitive behavioral therapy may be a useful and affordable intervention for patients with non-adherence to ketogenic diet. Copyright © 2015 John Wiley & Sons, Ltd.

Unverified Answer

Have there been any new discoveries for treating cognitive decline?

Add answer

The majority of recent findings to improve cognitive decline relate to the use of exercise and cognition. However, the use of exercise as a specific intervention for cognitive decline is highly understudied and a subject of much needed research.

Unverified Answer

How does motivational interviewing-cognitive behavioral therapy ketogenic nutrition adherence program work?

Add answer

The ketogenic nutrition adherence program (MAP) had positive short-term and long-term effects. The use of motivational interviewing-cognitive behavioral therapy-based interventions in patients with metabolic disorders, especially those who could be challenging when communicating nutrition recommendations, improves the potential for adherence to nutrition care and may lead to better health outcomes.

Unverified Answer

Does cognitive decline run in families?

Add answer

Cognitive disability and subtypes may be genetically mediated. The role of lifestyle factors such as diet, alcohol use and cigarette smoking on cognition needs to be explored further.

Unverified Answer

What is the average age someone gets cognitive decline?

Add answer

Data from a recent study revealed the average age of cognitive decline onset. By focusing on a patient's age of cognitive decline, healthcare practitioners can better understand and treat cognitive impairment.

Unverified Answer

Have there been other clinical trials involving motivational interviewing-cognitive behavioral therapy ketogenic nutrition adherence program?

Add answer

Results from a recent paper provide valuable information that could help providers use research-based methods to support patients by identifying and addressing barriers to ketogenic diet adherence and improving patients' nutritional self-management skills. If verified in larger trials, our results suggest that this approach would be a valuable addition to the patient education process to improve self-management and ultimately decrease the likelihood to regain weight.

Unverified Answer
See if you qualify for this trial
Get access to this novel treatment for Adherence, Patient by sharing your contact details with the study coordinator.